ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented at Kidney Week, the annual meeting of the American Society of Nephrology, held from Oct. 23 to 27 in San Diego.
Sree Abhilekha Purohit, M.B.B.S., from the Shadan Institute of Medical Sciences in Hyderabad, India, and colleagues evaluated the global burden of CKD in women in 2,014 countries from 1990 to 2021.
The researchers report that the average annual percentage change in prevalence increased by 2.10 percent, mortality by 3.39 percent, and disability-adjusted life-years by 2.48 percent. The highest incidence rates of CKD due to type 1 diabetes occurred in Eastern Europe (2.07 cases per 100,000 persons), while CKD due to type 2 diabetes was highest in the Middle East and North Africa (43 cases per 100,000 persons). CKD attributable to hypertension (25.18 cases per 100,000 persons) and glomerulonephritis (5.69 cases per 100,000 persons) was notably prevalent in the Middle East and North Africa and Central Latin America, respectively. New CKD was most substantially seen in those aged 70 to 74 years (1.66 million cases in 2021), while the highest mortality rates were observed among those aged 85 to 89 years (92,279 deaths in 2021).
"Type 2 diabetes mellitus was the leading cause of CKD-related deaths among women in 2021, followed by CKD due to hypertension," the authors write. "There is a critical need for increased awareness, education, and comprehensive campaigns aimed at women's health involving public stakeholders and clinicians to address and mitigate these impacts."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-02 06:00
Read more
- FDA Approves Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
- Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors
- Concussion Could Raise Depression, Burnout in Pro Hockey Players
- Oct. 7 Tragedy Spurs Israeli Researcher to Study Grief Over Sibling Loss
- Boehringer Receives U.S. FDA Breakthrough Therapy Designation and Initiates Two Phase III trials in MASH for Survodutide
- Too Much Fasting in Hospital Could Have Downside for Orthopedic Surgery Patients
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions